Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma | MicrobiomeTrials← Back to trialsNCT07729098
Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2027-01-01Est. Completion: 2029-01-01
Enrollment target: 18 participants Other microbiome trials you might be interested in
Chronic Subdural Hemorrhage (cSDH)
This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatmen…
New York, United StatesEst. completion Sep 1, 2028
Chronic Subdural Hematoma
Chronic subdural hematoma is a collection of blood and fluid on the surface of the brain that is common in older adults.…
Hefei, ChinaEst. completion Dec 2028